Delivery Order SPE2DB22D6029-SPE2DB25FLVSF
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,152.80 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/ml syringes. This competitive award, utilizing firm fixed-price contract terms, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,999.36 for Benlysta 400 mg vials, with an ultimate completion date of June 23, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,076.40 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml syringes. The contract, issued on August 11, 2025, carries a firm fixed price and is scheduled for completion by September 2, 2025. This is a competitive award with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used primarily to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector units on September 3, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $3,082.67 under firm fixed-price terms. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $6,152.80 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml syringes on September 5, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta (belimumab) is a biologic immunosuppressant used primarily in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector, with a ceiling value of $3,082.67. The contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025, and utilizes firm fixed-price pricing under a non-competitive, non-set-aside arrangement. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Benlysta 200 mg/ml auto-injector with a ceiling value of $9,248.01. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The order is scheduled for completion by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. Benlysta (belimumab) is a biologic...
- The Defense Logistics Agency awarded a $9,229.20 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml syringes, with an ultimate completion date of August 12, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis, representing a specialized pharmaceutical product within the federal...